Ionis says its trial of HTTRx, intended to lower huntingtin protein, is fully recruited and plans to extend it
Completely removing normal huntingtin in adults may disrupt healthy brain function, a recent study suggests.
WAVE Life Sciences launches PRECISION clinical trial to suppress the mutant Huntington's disease protein
Evolving CRISPR-Cas9 techniques can now be used to edit the HD gene in a living mouse brain.
A potential HD biomarker has been uncovered in a recent clinical study
Media reports of a wonder drug for neurodegenerative diseases like Huntington's disease are overhyped
HDBuzz summarises final day of the 2017 Huntington's Disease Therapeutics Conference in Malta
HDBuzz summarises all the science from the 2017 Huntington's Disease Therapeutics Conference in Malta - day 2
HDBuzz summarises all the science from the 2017 Huntington's Disease Therapeutics Conference in Malta - day 1
Two recent studies show how a cellular border control system goes wrong in HD, opening new avenues for HD research.
Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease